Table 1. Orally Administered Vaccine Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Orally Administered Vaccine Market Restraints

Table 3. Orally Administered Vaccine Market Trends

Table 4. Orally Administered Vaccine Industry Policy

Table 5. Global Orally Administered Vaccine Revenue by Company, 2019-2024, US$ million

Table 6. Global Orally Administered Vaccine Revenue Market Share by Company, 2019-2024

Table 7. Global Orally Administered Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Orally Administered Vaccine Sales Volume Market Share by Company, 2019-2024

Table 9. Global Orally Administered Vaccine Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Orally Administered Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Orally Administered Vaccine Manufacturers Product Type

Table 13. China Orally Administered Vaccine Revenue by Company, 2019-2024, US$ million

Table 14. China Orally Administered Vaccine Revenue Market Share by Company, 2019-2024

Table 15. China Orally Administered Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Orally Administered Vaccine Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Orally Administered Vaccine Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Orally Administered Vaccine Import & Export Trends

Table 19. Main Sources of China Orally Administered Vaccine Import

Table 20. Export Destination of China Orally Administered Vaccine

Table 21. Global Headquarters and Manufacturing Base of Orally Administered Vaccine Manufacturers

Table 22. Global Major Manufacturers, Orally Administered Vaccine Capacity Expansion and Future Plans

Table 23. Global Orally Administered Vaccine Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Orally Administered Vaccine Production by Region, 2019-2024, (K Units)

Table 25. Global Orally Administered Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Orally Administered Vaccine Upstream (Raw Materials)

Table 27. Global Orally Administered Vaccine Typical Customers

Table 28. Orally Administered Vaccine Typical Distributors

Table 29. By Type, Global Orally Administered Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Orally Administered Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Orally Administered Vaccine Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Orally Administered Vaccine Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Table 37. By Country, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Table 39. Merck Company Information, Head Office, Market Area and Industry Position

Table 40. Merck Orally Administered Vaccine Models, Specifications and Application

Table 41. Merck Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Merck Company Profile and Main Business

Table 43. Merck Recent Developments

Table 44. GSK Company Information, Head Office, Market Area and Industry Position

Table 45. GSK Orally Administered Vaccine Models, Specifications and Application

Table 46. GSK Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. GSK Company Profile and Main Business

Table 48. GSK Recent Developments

Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 50. Sanofi Orally Administered Vaccine Models, Specifications and Application

Table 51. Sanofi Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Sanofi Company Profile and Main Business

Table 53. Sanofi Recent Developments

Table 54. Lanzhou Institute Company Information, Head Office, Market Area and Industry Position

Table 55. Lanzhou Institute Orally Administered Vaccine Models, Specifications and Application

Table 56. Lanzhou Institute Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Lanzhou Institute Company Profile and Main Business

Table 58. Lanzhou Institute Recent Developments

Table 59. Serum Institute Company Information, Head Office, Market Area and Industry Position

Table 60. Serum Institute Orally Administered Vaccine Models, Specifications and Application

Table 61. Serum Institute Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Serum Institute Company Profile and Main Business

Table 63. Serum Institute Recent Developments

Table 64. Valneva Company Information, Head Office, Market Area and Industry Position

Table 65. Valneva Orally Administered Vaccine Models, Specifications and Application

Table 66. Valneva Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Valneva Company Profile and Main Business

Table 68. Valneva Recent Developments

Table 69. Shanghai United Cell Company Information, Head Office, Market Area and Industry Position

Table 70. Shanghai United Cell Orally Administered Vaccine Models, Specifications and Application

Table 71. Shanghai United Cell Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Shanghai United Cell Company Profile and Main Business

Table 73. Shanghai United Cell Recent Developments

Table 74. Bibcol Company Information, Head Office, Market Area and Industry Position

Table 75. Bibcol Orally Administered Vaccine Models, Specifications and Application

Table 76. Bibcol Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Bibcol Company Profile and Main Business

Table 78. Bibcol Recent Developments

Table 79. PaxVax Company Information, Head Office, Market Area and Industry Position

Table 80. PaxVax Orally Administered Vaccine Models, Specifications and Application

Table 81. PaxVax Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. PaxVax Company Profile and Main Business

Table 83. PaxVax Recent Developments

Table 84. Vabiotech Company Information, Head Office, Market Area and Industry Position

Table 85. Vabiotech Orally Administered Vaccine Models, Specifications and Application

Table 86. Vabiotech Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Vabiotech Company Profile and Main Business

Table 88. Vabiotech Recent Developments

Table 89. Tiantan Biological Company Information, Head Office, Market Area and Industry Position

Table 90. Tiantan Biological Orally Administered Vaccine Models, Specifications and Application

Table 91. Tiantan Biological Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Tiantan Biological Company Profile and Main Business

Table 93. Tiantan Biological Recent Developments

Table 94. EuBiologics Company Information, Head Office, Market Area and Industry Position

Table 95. EuBiologics Orally Administered Vaccine Models, Specifications and Application

Table 96. EuBiologics Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. EuBiologics Company Profile and Main Business

Table 98. EuBiologics Recent Developments

Table 99. Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

Table 100. Panacea Biotec Ltd Orally Administered Vaccine Models, Specifications and Application

Table 101. Panacea Biotec Ltd Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Panacea Biotec Ltd Company Profile and Main Business

Table 103. Panacea Biotec Ltd Recent Developments

Table 104. Bio-Med Company Information, Head Office, Market Area and Industry Position

Table 105. Bio-Med Orally Administered Vaccine Models, Specifications and Application

Table 106. Bio-Med Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Bio-Med Company Profile and Main Business

Table 108. Bio-Med Recent Developments

Table 109. Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 110. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Models, Specifications and Application

Table 111. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Halfkin Bio-Pharmaceuticals Company Profile and Main Business

Table 113. Halfkin Bio-Pharmaceuticals Recent Developments

List of Figure

Figure 1. Orally Administered Vaccine Picture

Figure 2. By Revenue, Global Orally Administered Vaccine Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Orally Administered Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Orally Administered Vaccine Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Orally Administered Vaccine Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Orally Administered Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Orally Administered Vaccine Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Orally Administered Vaccine Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Orally Administered Vaccine Share of Global Market, 2019-2030

Figure 10. Global Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Orally Administered Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Orally Administered Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Orally Administered Vaccine Domestic VS Export, 2022

Figure 16. Global Orally Administered Vaccine Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Orally Administered Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Orally Administered Vaccine Production Market Share & Forecast by Region, 2019-2030

Figure 19. Orally Administered Vaccine Industry Chain

Figure 20. Orally Administered Vaccine Procurement Model

Figure 21. Orally Administered Vaccine Sales Model

Figure 22. Orally Administered Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Rotavirus Vaccine

Figure 24. Cholera Vaccine

Figure 25. Oral Polio Vaccine

Figure 26. Other

Figure 27. By Type, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Figure 28. By Type, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 29. By Type, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 30. By Type, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 31. By Type, Global Orally Administered Vaccine Price, 2019-2030, (US$/Unit)

Figure 32. Public

Figure 33. Private

Figure 34. By Application, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 36. By Application, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global Orally Administered Vaccine Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 40. By Region, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 41. North America Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Orally Administered Vaccine Revenue Market Share, 2022

Figure 43. Europe Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Orally Administered Vaccine Revenue Market Share, 2022

Figure 45. Asia Pacific Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Orally Administered Vaccine Revenue Market Share, 2022

Figure 47. South America Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Orally Administered Vaccine Revenue Market Share, 2022

Figure 49. Middle East & Africa Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. Orally Administered Vaccine Market Share, 2022

Figure 52. By Type, U.S. Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe Orally Administered Vaccine Market Share, 2022

Figure 56. By Type, Europe Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 58. China Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China Orally Administered Vaccine Market Share, 2022

Figure 60. By Type, China Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan Orally Administered Vaccine Market Share, 2022

Figure 64. By Type, Japan Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea Orally Administered Vaccine Market Share, 2022

Figure 68. By Type, South Korea Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia Orally Administered Vaccine Market Share, 2022

Figure 72. By Type, Southeast Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 74. India Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India Orally Administered Vaccine Market Share, 2022

Figure 76. By Type, India Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia Orally Administered Vaccine Market Share, 2022

Figure 80. By Type, Middle East & Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches